nitrendipine has been researched along with c-peptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attali, JR; Perret, G; Uzzan, B; Valensi, P | 1 |
| Hökfelt, B; Hulthén, UL; Katzman, PL | 2 |
1 trial(s) available for nitrendipine and c-peptide
| Article | Year |
|---|---|
Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Double-Blind Method; Female; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Nifedipine; Nitrendipine; Obesity; Time Factors | 1991 |
2 other study(ies) available for nitrendipine and c-peptide
| Article | Year |
|---|---|
Unchanged insulin secretion and glucose tolerance but increased insulin clearance during long-term calcium antagonism with felodipine in essential hypertension.
Topics: Adult; Blood Glucose; C-Peptide; Calcium Channel Blockers; Felodipine; Homeostasis; Humans; Hypertension; Insulin; Insulin Secretion; Lipids; Male; Middle Aged; Nitrendipine | 1987 |
Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment.
Topics: Adult; Antihypertensive Agents; C-Peptide; Felodipine; Glucagon; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Nitrendipine | 1987 |